Analysts expect Quantum Biopharma Ltd. to report revenue of 2.10 M for Q1 25, against a range of 2.02 M to 2.18 M. The most recent reported quarter, Q4 25, came in at 0.00.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | 0.00 | 0.00 | 0.00 | - | - | - | - |
| High Estimate | 2.18 M | 3.24 M | 1.01 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Low Estimate | 2.02 M | 2.73 M | 859,259.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 2.10 M | 2.98 M | 933,957.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect Quantum Biopharma Ltd. to report earnings per share of -0.48 for Q3 26, against a range of -0.53 to -0.43. The most recent reported quarter, Q2 26, came in at -0.47, a 6.8% miss against the -0.44 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -2.78 | -2.89 | -3.53 | -3.23 | -1.25 | -0.19 | -3.06 | -0.47 | - | - |
| High Estimate | -2.53 | -0.70 | -0.66 | -0.17 | -2.37 | -0.91 | -0.44 | -0.42 | -0.43 | -0.67 |
| Low Estimate | -2.83 | -0.82 | -0.72 | -0.19 | -2.89 | -0.97 | -0.48 | -0.46 | -0.53 | -0.77 |
| Consensus Estimate | -2.68 | -0.76 | -0.69 | -0.18 | -2.63 | -0.94 | -0.46 | -0.44 | -0.48 | -0.72 |
Pull Wall Street consensus for Quantum Biopharma Ltd. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=QNTM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "QNTM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=QNTM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();